- Home
- AVDL vs NRK Comparison
AVDL vs NRK Comparison
Compare AVDL & NRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- NRK
- Stock Information
- Founded
- AVDL 2015
- NRK 2002
- Country
- AVDL Ireland
- NRK United States
- Employees
- AVDL N/A
- NRK N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- NRK Trusts Except Educational Religious and Charitable
- Sector
- AVDL Health Care
- NRK Finance
- Exchange
- AVDL Nasdaq
- NRK Nasdaq
- Market Cap
- AVDL 786.3M
- NRK 904.6M
- IPO Year
- AVDL 1996
- NRK N/A
- Fundamental
- Price
- AVDL $7.64
- NRK $10.55
- Analyst Decision
- AVDL Strong Buy
- NRK
- Analyst Count
- AVDL 6
- NRK 0
- Target Price
- AVDL $20.00
- NRK N/A
- AVG Volume (30 Days)
- AVDL 1.7M
- NRK 187.3K
- Earning Date
- AVDL 03-03-2025
- NRK 01-01-0001
- Dividend Yield
- AVDL N/A
- NRK 4.10%
- EPS Growth
- AVDL N/A
- NRK N/A
- EPS
- AVDL N/A
- NRK N/A
- Revenue
- AVDL $138,160,000.00
- NRK N/A
- Revenue This Year
- AVDL $515.63
- NRK N/A
- Revenue Next Year
- AVDL $49.32
- NRK N/A
- P/E Ratio
- AVDL N/A
- NRK N/A
- Revenue Growth
- AVDL 1523.50
- NRK N/A
- 52 Week Low
- AVDL $7.39
- NRK $8.95
- 52 Week High
- AVDL $19.09
- NRK $11.09
- Technical
- Relative Strength Index (RSI)
- AVDL 30.42
- NRK 50.84
- Support Level
- AVDL $7.40
- NRK $10.41
- Resistance Level
- AVDL $8.01
- NRK $10.60
- Average True Range (ATR)
- AVDL 0.44
- NRK 0.08
- MACD
- AVDL -0.07
- NRK 0.03
- Stochastic Oscillator
- AVDL 6.93
- NRK 85.39
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
About NRK Nuveen New York AMT-Free Quality Municipal Income Fund
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. Its investment objective is to provide current income exempt from regular federal, New York State, and New York City income taxes and from the federal alternative minimum tax applies to individuals and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.